Rehmannioside D

CAS No. 81720-08-3

Rehmannioside D ( —— )

Catalog No. M21470 CAS No. 81720-08-3

Rehmannioside D is a carotenoid glycoside that existed in the roots of Rehmannia glutinosa.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 99 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rehmannioside D
  • Note
    Research use only not for human use.
  • Brief Description
    Rehmannioside D is a carotenoid glycoside that existed in the roots of Rehmannia glutinosa.
  • Description
    Rehmannioside D is a carotenoid glycoside that existed in the roots of Rehmannia glutinosa.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    81720-08-3
  • Formula Weight
    686.61
  • Molecular Formula
    C27H42O20
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:130 mg/mL (189.34 mM)
  • SMILES
    OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1O[C@@H]([C@@H]1C(CO)=C[C@H]2O)OC=C[C@@]12O[C@@H]([C@@H]([C@H]1O)O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)O[C@H](CO)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MBP (68-82), guinea ...

    Myelin Basic Protein (68-82), guinea pig, is a peptide with the sequence Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn.Myelin Basic Protein (MBP) (68-82), guinea pig is a fragment of myelin basic protein (MBP).

  • MARK4 inhibitor 1

    MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis.?MARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM.?

  • Brilliant Black BN

    Brilliant black BN (E151) is an azo dye and a food colorant. It is a promising antiviral agent against EV71 infection via inhibiting the interaction between EV71 and its cellular uncoating factor cyclophilin A.